ArticleNature communications2023

A subset of type-II collagen-binding antibodies prevents experimental arthritis by inhibiting FCGR3 signaling in neutrophils.

Zhongwei Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.